News

Individual genetic testing did not improve uptake of colorectal cancer screening

Posted on: 20/10/2014 - 22:00

Counseling adults about their individual risk of colorectal cancer generally did not convince them to seek screening for the disease, according to a randomized controlled trial reported online...

Field of Interest: Oncology

Type: News Item

VIDEO: Causes of low libido in postmenopausal women are complex, don’t always require pharmacologic treatment

Posted on: 20/10/2014 - 21:11

NATIONAL HARBOR, MD. – Menopause is often accompanied by complex changes in sexual health and function, and factors contributing to low libido and other sexual problems in postmenopausal women may...

Field of Interest: Pulmonology

Type: News Item

AUDIO: Conjugated estrogen, bazedoxifene combo offers menopause treatment option

Posted on: 19/10/2014 - 21:07

NATIONAL HARBOR, MD. – Treating menopause symptoms in women who still have a uterus can be difficult, but alternatives to estrogen are available. For many women, the use of estrogen therapies is...

Field of Interest: Pulmonology

Type: News Item

C. difficile recurrences steady, but drive costly readmissions

Posted on: 19/10/2014 - 20:24

PHILADELPHIA – Every recurrence of Clostridium difficile was associated with a hospital admission in 1 in 4 cases and a complication in 1 in 15 cases, according to a retrospective Canadian...

Field of Interest: Gastroentero...

Type: News Item

Secukinumab showed sustained efficacy in psoriasis

Posted on: 19/10/2014 - 17:57

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology

Type: News Item

In psoriasis, is pushing for PASI 90 really worthwhile?

Posted on: 19/10/2014 - 15:40

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Dermatology

Type: News Item

In psoriasis, is pushing for PASI 90 really worthwhile?

Posted on: 19/10/2014 - 15:40

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Rheumatology

Type: News Item

VIDEO: Is the FDA’s black box on estrogen too ‘alarming’?

Posted on: 18/10/2014 - 18:22

NATIONAL HARBOR, MD. – Does the Food and Drug Administration’s black-box warning on estrogen contribute to noncompliance – or worse, to clinicians being unwilling to prescribe estrogen treatments –...

Field of Interest: Pulmonology

Type: News Item

FDA approves new abuse-prevention labeling for extended-release Embeda

Posted on: 18/10/2014 - 16:57

The Food and Drug Administration has approved new labeling for the opioid analgesic Embeda to include information about the drug’s abuse-preventive properties, the agency announced Oct. 17. The...

Field of Interest: Oncology

Type: News Item

Tocilizumab and tofacitinib increase lipids in RA patients

Posted on: 17/10/2014 - 22:34

Rheumatoid arthritis patients treated with the biologic tocilizumab and the Janus kinase inhibitor tofacitinib had significant changes to their lipid levels in a meta-analysis of randomized,...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters